The Vall d´Hebron Institute of Oncology (VHIO) Seeks a “Clinical Project Manager”
Application deadline: 30/04/2020
Number of vacancies: 1
- Responsible for the feasibility, selection, set up, conduct and closure of a clinical trial within the allocated countries, in accordance with the ICH-GCP, applicable legislation and VHIO Standard Operating Procedures.
- Responsible for the operational management of clinical studies, ensuring the compliance with timelines, milestones and budget.
- Act as the main line of communication to relevant stakeholders and provides input to feasibility, study design, budget development and ensures progress reporting (resources, budget and timelines).
- Manage clinical projects from concept through clinical study report completion
- Participates in meetings with investigators and other partners
- Provides input on study related documents (e.g. ICF, CRF, monitor plan, protocol, Lab manual etc.), set-up and maintain study files.
- Degree in health care, life sciences or related fields.
- Minimum of 5 years of experience in clinical trials (preferable in Oncology)
- Knowledge of clinical trial design and development.
- In-depth knowledge of GCP and local legislation.
- Excellent organization and management skills.
- Good negotiation and communication skills.
- Results oriented.
- Fluent in Spanish and English.
Application: Candidates must submit a curriculum vitae and letter of intent via email: firstname.lastname@example.org, including the reference number 05/2020.
Under the leadership of Josep Tabernero, the Vall d’Hebron Institute of Oncology (VHIO), has established itself as a comprehensive cancer center of proven excellence internationally. It is also thanks to VHIO’s optimal organizational structure based on a purely multidisciplinary and translational model that VHIO talents continue to anticipate and tackle the many unresolved questions in combatting this multifaceted and heterogeneous disease.
Located within the Vall d’Hebron Barcelona Hospital Campus, our researchers closely collaborate and interact with Vall d’Hebron physician-scientists. Translational science and clinical research are therefore tightly connected which promotes superb interaction and teamwork which, in turn, accelerates the bench-bedside-bed cycle of knowledge. This privileged environment affords VHIO direct access to patients as well as the entire spectrum of oncology professionals who care for them, and a second-to-none appreciation of how cancer science can translate into more powerful, targeted treatments and better practice for the care of patients.
VHIO’s pioneering model and programs, coupled with its belief in combining strengths through cross-border collaborations, continue to spur advances in reversing cancer resistance, halting metastatic spread, and more effectively treating even the most undruggable tumor types.
VHIO’s translation toward precision oncology: http://www.vhio.net
Vall d’Hebron Institute Oncology (VHIO) endorses the Requirements and Principles of the European Charter for Researchers, the Code of Conduct for the Recruitment of Researchers promoted by the European Commission and follows Equal Opportunities policies.
On 10th April 2018 VHIO was awarded the “HR Excellence in Research” logo. Our Institute was consequently granted permission to use the HR Excellence in Research Award logo as demonstration of its stimulating and favourable work environment in line with the Charter & Code.